Walden Group Healthcare M&A Blog

The Walden Group Releases 2022 Year-End Strategic Healthcare M&A Report

3/10/2023
The Walden Group is pleased to provide access to its Q4 2022 Strategic Healthcare M&A Report, which includes:  Recent Divestitures and Spin-Offs Diagnostic and Medical Device Deals with Valuations over $100m Noteworthy M&A Deals By Sector Top Deals > $100m in Transaction Value Announced or Closed in 2022 ...
Read More
Shockwave Medical to Acquire Neovasc for $100m

2/7/2023
Shockwave Medical, a $237m developer of technologies treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease, is acquiring Neovasc, a $2.5m Canada-based developer of transcatheter devices treating refractory angina and mitral valve disease. Deal terms – $100m upfront plus $47m in milestones...
Read More
Zimmer Biomet Acquires Embody for $150m

1/9/2023
Zimmer Biomet Holdings, Inc., a $8.0b maker of orthopedic reconstructive products is acquiring Embody, Inc., a developer of collagen implants for repairing tendons, ligaments and torn rotator cuffs. The acquisition builds Zimmer Biomet’s sports medicine offerings after it spun-off its dental and spine operations into Zimvie, a separate,...
Read More
The Walden Group Represented Total Titanium, Inc in Its Sale to a Subsidiary of Bausch + Lomb Corporation

12/21/2022
The Walden Group is pleased to announce that it represented Total Titanium, Inc. (TTI) in its sale to a subsidiary of Bausch + Lomb Corporation (NYSE/TSX:BLCO) (“Bausch + Lomb”). TTI was one of the last remaining independently-owned manufacturers of precision ophthalmic instruments based in the United States. Bausch + Lomb is a leading global...
Read More
The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report

11/8/2022
The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes: Market Overview -- What you need to know about MDR and more Major M&A Deals by Sector For Ophthalmology, Orthopedic & Spine, and Woundcare - Key Developments and Deals Key Stats on Top...
Read More